top of page

Combating Drug Resistant Bacterial Infections
Our novel antibiotic is being developed for treatment of antibiotic resistant pathogens such as MRSA.
Board of Directors
Our board is composed of experts in a wide variety of fields, dedicated to guiding the growth of our business and the development of our technologies. Our directors ensure that Sano continues to achieve excellence in innovation and provide direction as we achieve milestones.
bottom of page